P. Veng‐Pedersen

发表

Kinetic evaluation of nonlinear drug elimination by a disposition decomposition analysis. Application to the analysis of the nonlinear elimination kinetics of erythropoietin in adult humans.

J. Widness, P. Veng‐Pedersen, R. Schmidt, 1995, Journal of pharmaceutical sciences.

Pharmacokinetics and pharmacodynamics of erythropoietin during therapy in an infant with renal failure.

J. Widness, P. Kling, P. Veng-Pedersen, 1992, The Journal of pediatrics.

A Tracer Interaction Method for Nonlinear Pharmacokinetics Analysis: Application to Evaluation of Nonlinear Elimination

J. Widness, P. Veng-Pedersen, J. A. Widness, 1997, Journal of Pharmacokinetics and Biopharmaceutics.

The effect of anticoagulant, storage temperature and dilution on cord blood hematology parameters over time

J. Widness, K. Freise, R. Schmidt, 2009, International journal of laboratory hematology.

Change in Erythropoietin Pharmacokinetics Following Hematopoietic Transplantation

J. Widness, K. Freise, F. Goldman, 2007, Clinical pharmacology and therapeutics.

Receptor-based model accounts for phlebotomy-induced changes in erythropoietin pharmacokinetics.

J. Widness, S. Chapel, R. Schmidt, 2001, Experimental hematology.

In vivo 125I-erythropoietin pharmacokinetics are unchanged after anesthesia, nephrectomy and hepatectomy in sheep.

J. Widness, R. Schmidt, J. Kisthard, 1996, The Journal of pharmacology and experimental therapeutics.

Developmental differences in erythropoietin pharmacokinetics: increased clearance and distribution in fetal and neonatal sheep.

J. Widness, D. Chestnut, N. Modi, 1992, The Journal of pharmacology and experimental therapeutics.

Erythropoietin pharmacokinetics in premature infants: developmental, nonlinearity, and treatment effects.

J. Widness, C. Peters, R. Schmidt, 1996, Journal of applied physiology.

A pharmacodynamic analysis of erythropoietin-stimulated reticulocyte response in phlebotomized sheep.

J. Widness, S. Chapel, R. Schmidt, 2000, The Journal of pharmacology and experimental therapeutics.

Individualized pharmacokinetic risk assessment for development of diabetes in high risk population.

N. Al-Huniti, P. Veng-Pedersen, N. Gupta, 2007, Diabetes research and clinical practice.

A system approach to pharmacodynamics. Plasma iron mobilization by endogenous erythropoietin in the sheep fetus; evidence of threshold response in spontaneous hypoxemia.

M. Georgieff, J. Widness, N. Modi, 1993, Journal of pharmaceutical sciences.

A sensitive and specific erythropoietin immunoprecipitation assay: application to pharmacokinetic studies.

J. Widness, N. Modi, R. Schmidt, 1992, The Journal of laboratory and clinical medicine.